Status:
COMPLETED
DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Subjective Cognitive Decline
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
More than 4.4 million patients receive home health services following discharge from the hospital or rehabilitation facility. A substantial number (70%) are older adults with subjective cognitive decl...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Home Health patients
- 1\) Home health service patients aged \> 50 years with SCD, with an OASIS- Cognition Function Subscale Score of 1 or 2 (0 = alert/oriented, able to focus and shift attention, comprehends and recalls task directions independently; 1 = Requires prompting \[cuing, repetition, reminders) only under stressful or unfamiliar conditions; 2 = Requires assistance and some direction in specific situations \[for example, on all tasks involving shifting of attention\] or consistently requires low stimulus environment due to distractibility; 3 = Requires considerable assistance in routine situations. Is not alert and oriented or is unable to shift attention and recall directions more than half the time; 4 = Totally dependent due to disturbances such as constant disorientation, coma, persistent vegetative state, or delirium.
- Exclusion:
- No caregiver
- Criteria for home health services sites are: 1) a minimum of 300 or more new patients/per site annually; 2) at least 50% w/ length of service \> 60 days; 3) staff-to-patient ratio complies with Home Health Agency requirements; 4) no severe state issues. Prior to randomization, sites meeting these criteria will be determined in consultation with the KAH, Clinical Operations Coordinator.
- KAH staff including call-center care coordinators, clinical assessment associates, field-based therapists, and clinical operational coordinator
Exclusion
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04796415
Start Date
May 1 2021
End Date
August 31 2022
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kindred at Home
Indianapolis, Indiana, United States, 46032